Skip to main content
Year archive

RECCE PHARMACEUTICALS LTD — 2020 filings

All 94 regulatory filings released by RECCE PHARMACEUTICALS LTD (RCE) in 2020, sourced directly from the official regulator.

94 Filings
2020 Period
2020 filings (94)
Filing Released Lang
Positive Intranasal Animal Data against SARS-CoV-2 in Study 3 pages 559.4KB
Regulatory Filings
2020-12-22 English
Business Update 3 pages 447.5KB
Regulatory Filings
2020-12-15 English
Change of Director's Interest Notice 3 pages 402.6KB
Regulatory Filings
2020-12-10 English
RCE Awarded AusIndustry Advanced Overseas Anti-Viral Finding 2 pages 380.3KB
Regulatory Filings
2020-12-07 English
Appendix 2A 15 pages 225.5KB
Regulatory Filings
2020-12-03 English
Cleansing Statement 1 page 214.7KB
Regulatory Filings
2020-12-03 English
RCE AGM Presentation 16 pages 3.2MB
Regulatory Filings
2020-11-29 English
Results of Meeting 3 pages 218.7KB
Regulatory Filings
2020-11-29 English
Recce Awarded AusIndustry Advanced Overseas (R&D) Finding 2 pages 341.2KB
Regulatory Filings
2020-11-25 English
Anti-Viral Patent Granted in Japan for RECCE Anti-Infectives 2 pages 307.6KB
Regulatory Filings
2020-11-22 English
Extension of Voluntary Suspension 1 page 258.7KB
Regulatory Filings
2020-11-09 English
Encouraging Results Against SARS-CoV-2 Virus 3 pages 467.0KB
Regulatory Filings
2020-11-09 English
Reinstatement to Official Quotation 1 page 409.1KB
Regulatory Filings
2020-11-09 English
Extension of Voluntary Suspension 1 page 257.2KB
Regulatory Filings
2020-11-08 English
Suspension from Official Quotation 2 pages 435.0KB
Regulatory Filings
2020-11-04 English
Trading Halt 2 pages 477.9KB
Regulatory Filings
2020-11-02 English
Investor Presentation 29 pages 4.4MB
Regulatory Filings
2020-10-29 English
Notice of Annual General Meeting/Proxy Form 63 pages 1.8MB
Regulatory Filings
2020-10-29 English
Letter to Shareholders - Annual General Meeting 2 pages 337.0KB
Regulatory Filings
2020-10-29 English
Appendix 4C and Activity Report 10 pages 818.9KB
Regulatory Filings
2020-10-20 English
HREC Approval to Start Phase I/II Burns Wound Study 3 pages 342.9KB
Regulatory Filings
2020-10-15 English
Pause in trading 1 page 111.5KB
Regulatory Filings
2020-10-13 English
Trading Halt 2 pages 478.5KB
Regulatory Filings
2020-10-13 English
R&D Incentive Rebate Received 2 pages 326.3KB
Regulatory Filings
2020-10-04 English
Murdoch Children's Research Institute, R435 Against H.Pylori 3 pages 387.4KB
Regulatory Filings
2020-09-29 English
Recce Appoints Michele Dilizia as Chief Scientific Officer 3 pages 361.2KB
Regulatory Filings
2020-09-29 English
2020 Annual General Meeting 2 pages 324.7KB
Regulatory Filings
2020-09-29 English
Issue of Placement Shares 2 pages 346.8KB
Regulatory Filings
2020-09-29 English
Appendix 2A 15 pages 292.5KB
Regulatory Filings
2020-09-29 English
Appendix 2A 15 pages 293.4KB
Regulatory Filings
2020-09-29 English
Cleansing Statement 1 page 252.1KB
Regulatory Filings
2020-09-29 English
Appendix 3G 12 pages 275.2KB
Regulatory Filings
2020-09-29 English
Top 20 Shareholders Update 3 pages 228.6KB
Regulatory Filings
2020-09-29 English
Change in substantial holding 3 pages 255.9KB
Regulatory Filings
2020-09-29 English
Recce Completes Capital Raising of $27.95m 3 pages 362.9KB
Regulatory Filings
2020-09-22 English
Proposed issue of Securities - RCE 6 pages 30.7KB
Regulatory Filings
2020-09-22 English
Trading Halt 2 pages 521.1KB
Regulatory Filings
2020-09-20 English
R327 Phase I Study - Australia's CMAX Clinical Facility 3 pages 379.2KB
Regulatory Filings
2020-09-09 English
Positive & Concentration-Dependent Efficacy Against COVID-19 4 pages 599.2KB
Regulatory Filings
2020-09-07 English
Comment on Media Article Published in AFR 1 page 25
Regulatory Filings
2020-09-07 English
Pause in Trading 1 page 111.5KB
Regulatory Filings
2020-09-06 English
Trading Halt 2 pages 666.6KB
Regulatory Filings
2020-09-06 English
Change of Director's Interest Notice 2 pages 223.9KB
Regulatory Filings
2020-09-01 English
Change of Director's Interest Notice 3 pages 224.5KB
Regulatory Filings
2020-09-01 English
Recce Pharmaceuticals Receives Innovation Connections Grant 2 pages 319.1KB
Regulatory Filings
2020-08-31 English
Recce Pharmaceuticals Appoints James Graham as CEO 3 pages 371.7KB
Regulatory Filings
2020-08-27 English
Appendix 4E 4 pages 187.6KB
Regulatory Filings
2020-08-27 English
2020 Annual Report 72 pages 2.5MB
Regulatory Filings
2020-08-27 English
Appendix 4G 10 pages 171.0KB
Regulatory Filings
2020-08-27 English
Appendix 2A 14 pages 81.3KB
Regulatory Filings
2020-08-27 English
Cleansing Statement 1 page 176.3KB
Regulatory Filings
2020-08-27 English
Appointment of H. Pylori Expert Prof Sutton to Dev Program 3 pages 343.5KB
Regulatory Filings
2020-08-20 English
Conversion of Performance Shares 2 pages 346.2KB
Regulatory Filings
2020-08-16 English
Positive Oral Data on New RECCE 435 Against H. pylori 5 pages 777.2KB
Regulatory Filings
2020-08-03 English
Investor Presentation 29 pages 4.1MB
Regulatory Filings
2020-08-03 English
Appendix 4C and Activity Report 9 pages 490.4KB
Regulatory Filings
2020-07-30 English
Opening Address at 2020 World Antibiotic Resistance Congress 2 pages 421.7KB
Regulatory Filings
2020-07-22 English
Correction - CSIRO SARS-CoV-2 Antiviral Screening Program 1
Regulatory Filings
2020-07-19 English
Pause in Trading 1 page 111.0KB
Regulatory Filings
2020-07-15 English
US Researchers to Test RECCE in Expanded SARS-CoV-2 Program 3 pages 342.7KB
Regulatory Filings
2020-07-15 English
Recce Adds Biotech Veteran Alan W. Dunton M.D. to its Board 3 pages 312.7KB
Regulatory Filings
2020-07-13 English
Initial Director's Interest Notice 2 pages 166.2KB
Regulatory Filings
2020-07-13 English
Change in substantial holding 3 pages 247.0KB
Regulatory Filings
2020-07-12 English
Change of Director's Interest Notice 3 pages 224.8KB
Regulatory Filings
2020-07-12 English
Change of Director's Interest Notice 3 pages 222.5KB
Regulatory Filings
2020-07-12 English
Appendix 2A 14 pages 105.9KB
Regulatory Filings
2020-07-08 English
Cleansing Statement 1 page 206.0KB
Regulatory Filings
2020-07-08 English
Suspension from Official Quotation 2 pages 342.1KB
Regulatory Filings
2020-07-07 English
RCE Selected by CSIRO/PDI for SARS-CoV-2 Antiviral Program 3 pages 368.0KB
Regulatory Filings
2020-07-07 English
Reinstatement to Official Quotation 1 page 412.4KB
Regulatory Filings
2020-07-07 English
Pause in Trading 1 page 110.6KB
Regulatory Filings
2020-07-05 English
Trading Halt 2 pages 478.8KB
Regulatory Filings
2020-07-05 English
Resignation of Director & CRO Dr. Graham Melrose 2 pages 329.9KB
Regulatory Filings
2020-07-02 English
Final Director's Interest Notice 2 pages 198.6KB
Regulatory Filings
2020-07-02 English
Conversion of Performance Shares 2 pages 316.6KB
Regulatory Filings
2020-06-25 English
Response to ASX Price and Volume Query 3 pages 313.9KB
Regulatory Filings
2020-05-26 English
Corporate Presentation - May 2020 31 pages 3.4MB
Regulatory Filings
2020-05-20 English
Appendix 2A 15 pages 43.4KB
Regulatory Filings
2020-05-20 English
Cleansing Statement 1 page 184.5KB
Regulatory Filings
2020-05-20 English
Positive Data on RECCE 327 Against Neisseria gonorrhoeae 4 pages 464.7KB
Regulatory Filings
2020-05-03 English
Appendix 4C and Activity Report 7 pages 413.4KB
Regulatory Filings
2020-04-28 English
Further Positive Data on RECCE 327 Against MRSA Superbug 4 pages 897.3KB
Regulatory Filings
2020-04-22 English
Positive Data on RECCE 327 Against Influenza A 4 pages 588.8KB
Regulatory Filings
2020-04-19 English
Trading Halt 2 pages 280.4KB
Regulatory Filings
2020-04-15 English
Recce Signs Phase I Human Clinical Trial Agreement 3 pages 278.5KB
Regulatory Filings
2020-04-07 English
First-in-Human Clinical Trial Progress Update 2 pages 340.9KB
Regulatory Filings
2020-03-16 English
Half Yearly Report and Accounts 27 pages 398.9KB
Regulatory Filings
2020-02-26 English
Appendix 2A 16 pages 334.9KB
Regulatory Filings
2020-02-26 English
Cleansing Statement 1 page 184.6KB
Regulatory Filings
2020-02-26 English
Positive Efficacy Data in Kidney/UTI infections animal model 4 pages 566.7KB
Regulatory Filings
2020-02-13 English
Positive Data from RECCE 327 Antibiotic Safety Studies 6 pages 996.5KB
Regulatory Filings
2020-02-09 English
Appendix 4C and Commentary 6 pages 767.3KB
Regulatory Filings
2020-01-30 English
Appendix 2A 15 pages 283.8KB
Regulatory Filings
2020-01-15 English
Cleansing Statement 1 page 184.9KB
Regulatory Filings
2020-01-15 English